Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Claims 1 - 22 were cancelled prior to approval as part of the back and forth. The only remaining claims at time of approval were 23 - 27 and they are specific to melanoma. If you go to public pair, put in either the patent number 9,180,106 or the application number you cited, then bring up the Image File Wrapper and check for the LATEST claims you'll see only claims 23 - 27.
I have no idea why they create those long winded titles the way they do. It could be that all that extra verbiage is simply repeated from the original composition of matter patent from years ago and they just maintain it in derivative patents. I have spoken to a friend of mine who is a retired patent attorney and he said legal protection is limited to the claims and must be in the claims section.
As anecdotal evidence of this note the oft reported on battle going on with the Anavex Plus patent application. As the back an forth has continued there has been no changes (that I've seen) made to the title or abstract in order to push the process forward. After every rejection the claims have been adjusted to try to gain approval. If the title or abstract was critical to what specifically is being claimed it would be changing with every rejection.
Legally it doesn't matter what is said in the title. What is being "claimed" are in the "claims". Did you read the claims? Every single one cites treatment of cancer ONLY.
"Either way folks, it looks as if we have hard patent protection for MS until 2035."
Maybe via some other patent, but not using that patent application you cited. That's the old application for the patent granted in 2015 for treating cancer and nothing but cancer. See the claims.
That patent is for treating cancer and has nothing to do with Alzheimers.
Someone dumps a 12k block right as amateur hour is ending. What a surprise.
One flaw with the idea that the options guys will pin it at $5 is the fact that at last count there are over 5 million shares short. If the shorts take advantage of this drop to cover it seems to me a much greater price moving force than 200K shares worth of $5 options.
The geniuses who set up this system for the fleecing of retail investors rotate in and out of top positions at the SEC. A lot of them come from Goldman Sachs. A SEC that would agree to the removal of the uptick rule just so hedge funds could conduct bear raids has no concern for retail investors.
Maybe just journalistic laziness. Real investigative journalism requires money and hard work. Maybe if there were easily accessible US patients along with someone like Macfarlane to talk with it would be different.
I'm looking to buy more today and if it's true they want to make the $5 options worthless then a bit of patience may be required especially if there's no early drop. Obviously the only price of concern to the option trashers is the closing price.
What I dont understand about forcing the options to be worthless is the amount of profit relative to the cost of the manipulation. If they have to short it down today and tomorrow using many multiples of the $5 open interest (200K shares?) then they'll need to cover those shorted shares starting next week. If it were to pop back up quickly (sans their negative influence) they could lose more on the manipulation than they made on the options?
".... Can this pivot low at 5.22 be trusted now to hold? what do y'all expect AVXL to do now....go Soaring back up to 6.60 again ? or would it wallow down here around 5 dollars. will it hit 5 dollars and then Jump? it could....
or maybe it will climb back now to test 6 dollars and then watch out...it could get Hammered down again there and target the 1 dollar plunge again to 5 dollars or 4.80 or any of the target steps down there. What dry powder do I have left to start adding some here,from 5.20 and still be able to add at 4.40/ yes 4.40 or 4.60 ."
Good grief! This is why I do only basic TA by eyeballing longer term charts to look for obvious upward ski slopes to sell into and washout periods to buy. Anything more detailed ends up like.. "If it goes up and goes through level "x" then it could easily go up to "y" and if it gets through that it could go to "z" but if it doesn't go up it could go down to "a" and if it doesn't hold there it could go to "b" and if that fails "c". The only thing missing from that kind of impressive sounding prediction is commitment to either the direction or magnitude of the move.
So how many $5 options are open?
At least Leo will be able to get back in.
Looks like low SLB is no guarantee against a big attack.
Looks like the grand fleecing is about over. I'd contact someone at the SEC but they're probably on the phone checking that today's kickback made it safely to their Swiss account.
100 share selling bot drilling away. If it gets the price back down to the bottom of the uptrend I'll buy some more.
Looks like $6.30 is the new absorption level.
8K bid just sitting there swallowing up all retail sales.
I think a modicum of basic TA IS important for "story" stocks that don't have revenue or profits. These kind of stocks tend to be manipulated far above where they would normally go (sans the manipulation) on good news and far below where they should on marginal/ho-hum news that's spun by manipulators as a disaster. Even just the basic TA of looking at a long term daily chart can help in gauging these "mispricings" by simply looking at the previous mispricing moves. There are folks here sitting on totally free positions because of prudently trading those moves.
Xena, for those of us who don't play options could you give just a brief comment on what you see in that chain?
" Mentioning 10 is a bit hyperbolic don't you think. ??."
I was diagnosed as hyperbolic as a child.
Trading like it wants to go to $10. Shares snapped up on every pullback.
It's hard to believe this is real. We've been screwed and manipulated so many times before. Could the stock price actually be ascending to where it reasonably belongs?
Yes, and I know for a fact that not all longs held after that mid year update that seemed so disappointing when compared to what was expected.
I know a few (relatives of mine who are NOT active traders) that sold most/all of their shares and sat on the sidelines until this latest update.
Who was being "manipulated" if retail longs were just sitting steadfastly on their long shares? It takes two to tango. You can't just set up an "algo" to ping pong shares back and forth between your own accounts and make money with only that.
How would LPC somehow cause this big move in the stock in order to sell into? There's no real news causing this. If it was just them they'd have to be buying as much as they intend to sell. Doesn't make sense to me.
Well if the stock is "shorted down" in the repeated cycles we've seen in the last year then who was it that sold the shorts the shares they needed to cover in these cycles?
With all due respect there is no way using a chart to distinguish a sell and a short sell.
If tutes are buying and retail is selling then what is this strategy someone is using putting up big blocks (e.g. 60K+) on the ask? Happening a lot during this run. Scare tactic aimed at retail investors? or just one tute trying to get out on the back of some other getting in? Seems to me it has to be a scare tactic otherwise the seller would not show an offer that large.
I agree and for that reason I've held onto more of my trading shares than I normally do at this point in a run. I'm still not fully trusting this situation however since this aggressive buyer could just be a big short who miscalculated the direction of the XBI and markets in general and is now in big trouble. That kind of almost "panic" buying never lasts.
We just disagree then. If as Zena just said, most of the holders of the stock are retail, all you have to do is look at a daily chart going back to 2015 to see how fast people dump for a profit when the stock makes one if its runs going up a dollar or two. Leo has traded this fact brilliantly. People trade much more than they are willing to admit when a big move occurs on minor news or no news at all. If you knew in advance someone was going to start gobbling up every share aggressively and bid the stock way way up until they completed an acquisition you might not sell on a 500% run up but you cannot know that in advance. What you do know is the lesson of the past which is that big corrections come quickly after big runs.
And how much did that stock collapse after missing the endpoint? Did the premium put the value of the stock back to it's previous high? AVXL stock has never seen the kind of collapse that it would see if 2-73 had clearly failed in the current phase of testing. There are always special cases but in general nobody pays 10x for a public company when the shares can be had on the open market for 1/10 that price. The acquirer would be better off just buying the stock on the open market. You may not get every last share before it reaches the 10x price but you'll probably get most of it.
Regardless of the estimated value, no company buys another public company for 10x (or more) the current stock price. Even 2x is unheard of.
Starting to feel like there's a short in trouble. Not much patience in this buying.
FT reporting investors piling into risky junk bonds. IMO, if they'll pile into those they'll pile into small cap bio and drive the XBi to new highs.
It's not helping the shorts any that the XBI is starting to edge up towards the Sept high around $69. If it should break hard through that top bio shorts are escrooweddd as inspector Clouseau would say.
What have you seen so far with those call options?
Ok, how about for either 50, 100, or 200 days ?
;)
"Does this finally put the patent issue to rest"
Which patent issue are you referring to? Patent coverage for Alzheimer's treatment? If that is "the issue" then no it does not. The statement refering to the 2035 date is the identical statement contained in the Anavex 2015 PR that announced approval of the patent for using 2-73 to treat cancer. It covers cancer and only cancer. So, is it valid to say there is some form of IP protection out until 2035? Yes, but that does not include AD treatment. The devil is always in the details and most of the time the details, especially regarding patent coverage, are not given in PR's.
The volume is very low this morning. It looks like bait to me. As in short sellers wanting to bait retail guys into chasing.